Ambulatory Cardiac Monitoring Devices Procedures performed till 2018 Table 14: Ambulatory Cardiac Monitoring Devices Procedures performed after January 2019 Table 15: Global Cardiovascular Diagnostic ...
The U.S. Food and Drug Administration (FDA ... Class 1 recalls issued by the FDA across multiple product categories. According to the data available on the FDA's website, medical devices and ...
Crecelac and Farmalac-branded infant formula is being recalled after being placed on shelves without proper evaluation by the Food and Drug Administration (FDA). Dairy Manufacturers Inc. issued a ...
The Optum recall applies to 208 devices. "We are committed to providing ... and we are complying with FDA requirements related to this matter. Optum has not had any report of injury from our ...
The formula had not been evaluated by the FDA to determine whether it meets U.S. food safety and nutritional standards, though the company said in a release accompanying the announcement that no ...
The same bacteria sparked recalls and shortages of infant formula ... Texas, according to the FDA. Press releases from the FDA and the company did not specify where the product was produced ...
DUBLIN, May 30, 2024--(BUSINESS WIRE)--Dublin-based FIRE1 today announced that the first Irish patient has been successfully implanted with its FIRE1™ System for remote heart failure monitoring.
The first ever Irish patient has been successfully implanted with an innovative device to monitor heart failure at home. The procedure, which took place at University Hospital Galway (UHG), is the ...
today announced FDA’s grant of “Breakthrough Device” designation 1 for its Canturio ® Lumbar Cartridge (canturio ® lc) with Canary Health Implanted Reporting Processor (CHIRP ®) System.
On February 20, 2024, Medline Industries, LP initiated a nationwide recall of 6 SubG Endotracheal Tubes with Subglottic Suction and 10 kits that contain these devices.